OSO Bio

Susan Schniepp has been appointed vice president of quality at OSO BioPharmaceuticals Manufacturing. Ms. Schniepp will manage all operational quality-related issues and is responsible for cGMP compliance of OsoBio’s facility, including validation, regulatory affairs, and records and filings.

Ms. Schniepp has more than 30 years of professional experience managing
quality assurance within the pharmaceutical industry. Recently, she served as chairwoman of the Monograph Development–Psychiatrics and Psychoactives Expert Committee for United States Pharmacopeia (USP).

“Sue is so highly regarded for her expertise in pharmaceutical quality that industry leaders frequently seek out her knowledge and leadership for the benefit of the general public,” said Stuart Rose, president and chef executive officer of OsoBio. “Sue is a great addition to the OsoBio team and an asset to the clients we serve.”

Prior to joining the company, she worked in quality affairs at Abbott Labs, Antisoma PLC, Hospira and Javelin Pharmaceuticals.